Literature DB >> 27075820

Effects of the Post-Spinal Cord Injury Microenvironment on the Differentiation Capacity of Human Neural Stem Cells Derived from Induced Pluripotent Stem Cells.

Clara López-Serrano1, Abel Torres-Espín1, Joaquim Hernández1, Ana B Alvarez-Palomo2, Jordi Requena2, Xavier Gasull3,4, Michael J Edel2,5,6, Xavier Navarro1.   

Abstract

Spinal cord injury (SCI) causes loss of neural functions below the level of the lesion due to interruption of spinal pathways and secondary neurodegenerative processes. The transplant of neural stem cells (NSCs) is a promising approach for the repair of SCI. Reprogramming of adult somatic cells into induced pluripotent stem cells (iPSCs) is expected to provide an autologous source of iPSC-derived NSCs, avoiding the immune response as well as ethical issues. However, there is still limited information on the behavior and differentiation pattern of transplanted iPSC-derived NSCs within the damaged spinal cord. We transplanted iPSC-derived NSCs, obtained from adult human somatic cells, into rats at 0 or 7 days after SCI, and evaluated motor-evoked potentials and locomotion of the animals. We histologically analyzed engraftment, proliferation, and differentiation of the iPSC-derived NSCs and the spared tissue in the spinal cords at 7, 21, and 63 days posttransplant. Both transplanted groups showed a late decline in functional recovery compared to vehicle-injected groups. Histological analysis showed proliferation of transplanted cells within the tissue and that cells formed a mass. At the final time point, most grafted cells differentiated to neural and astroglial lineages, but not into oligodendrocytes, while some grafted cells remained undifferentiated and proliferative. The proinflammatory tissue microenviroment of the injured spinal cord induced proliferation of the grafted cells and, therefore, there are possible risks associated with iPSC-derived NSC transplantation. New approaches are needed to promote and guide cell differentiation, as well as reduce their tumorigenicity once the cells are transplanted at the lesion site.

Entities:  

Keywords:  Cell therapy; Differentiation; Induced pluripotent stem cells (iPSCs); Neural stem cells (NSCs); Spinal cord injury (SCI)

Mesh:

Substances:

Year:  2016        PMID: 27075820     DOI: 10.3727/096368916X691312

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  14 in total

1.  Human Cord Blood-Derived CD133+/C-Kit+/Lin- Cells Have Bipotential Ability to Differentiate into Mesenchymal Stem Cells and Outgrowth Endothelial Cells.

Authors:  Carlos Cardenas; Ja-Young Kwon; Yong-Sun Maeng
Journal:  Stem Cells Int       Date:  2016-12-18       Impact factor: 5.443

Review 2.  On the Viability and Potential Value of Stem Cells for Repair and Treatment of Central Neurotrauma: Overview and Speculations.

Authors:  Samantha Wu; Kevin T FitzGerald; James Giordano
Journal:  Front Neurol       Date:  2018-08-13       Impact factor: 4.003

3.  Multifunctionalized hydrogels foster hNSC maturation in 3D cultures and neural regeneration in spinal cord injuries.

Authors:  Amanda Marchini; Andrea Raspa; Raffaele Pugliese; Marina Abd El Malek; Valentina Pastori; Marzia Lecchi; Angelo L Vescovi; Fabrizio Gelain
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-28       Impact factor: 11.205

4.  Progress in the Use of Induced Pluripotent Stem Cell-Derived Neural Cells for Traumatic Spinal Cord Injuries in Animal Populations: Meta-Analysis and Review.

Authors:  Christina Ramotowski; Xianggui Qu; Luis G Villa-Diaz
Journal:  Stem Cells Transl Med       Date:  2019-03-22       Impact factor: 6.940

Review 5.  Recent Progress in the Regeneration of Spinal Cord Injuries by Induced Pluripotent Stem Cells.

Authors:  Maria Csobonyeiova; Stefan Polak; Radoslav Zamborsky; Lubos Danisovic
Journal:  Int J Mol Sci       Date:  2019-08-06       Impact factor: 5.923

6.  Tissue-type plasminogen activator-primed human iPSC-derived neural progenitor cells promote motor recovery after severe spinal cord injury.

Authors:  Yasuhiro Shiga; Akina Shiga; Pinar Mesci; HyoJun Kwon; Coralie Brifault; John H Kim; Jacob J Jeziorski; Chanond Nasamran; Seiji Ohtori; Alysson R Muotri; Steven L Gonias; Wendy M Campana
Journal:  Sci Rep       Date:  2019-12-17       Impact factor: 4.379

7.  Effects of neural stem cell transplantation on the motor function of rats with contusion spinal cord injuries: a meta-analysis.

Authors:  Kai Qian; Tuo-Ye Xu; Xi Wang; Tao Ma; Kai-Xin Zhang; Kun Yang; Teng-Da Qian; Jing Shi; Li-Xin Li; Zheng Wang
Journal:  Neural Regen Res       Date:  2020-04       Impact factor: 5.135

8.  Stem Cell Therapy for Spinal Cord Injury.

Authors:  Liyi Huang; Chenying Fu; Feng Xiong; Chengqi He; Quan Wei
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

9.  Microglia Stimulation by Protein Extract of Injured Rat Spinal Cord. A Novel In vitro Model for Studying Activated Microglia.

Authors:  Joaquim Hernández; Isaac Francos-Quijorna; Elena Redondo-Castro; Rubén López-Vales; Xavier Navarro
Journal:  Front Mol Neurosci       Date:  2021-05-20       Impact factor: 5.639

10.  ReMeDy: a platform for integrating and sharing published stem cell research data with a focus on iPSC trials.

Authors:  Kirill Borziak; Irena Parvanova; Joseph Finkelstein
Journal:  Database (Oxford)       Date:  2021-06-22       Impact factor: 4.462

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.